EU Council Calls for Discussions On New Pricing Mechanisms
Transparency on pricing and cost calculations could improve and inform public policy on medicines access, say EU health ministers.
You may also be interested in...
The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.
England’s Innovative Medicines Fund is aimed at providing earlier access to promising new treatments, including gene therapies, when further data is needed for routine commissioning.
England’s health technology assessment body NICE did not recover costs for technology appraisals through fees thanks to the COVID-19 pandemic.